cas 943122-71-2|| where to buy 2-((4-(piperazin-1-yl)phenyl)amino)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)pyrimidine-4-carboxamide

Nom du produit:2-((4-(piperazin-1-yl)phenyl)amino)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)pyrimidine-4-carboxamide

IUPAC Name:2-{[4-(piperazin-1-yl)phenyl]amino}-N-{1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}pyrimidine-4-carboxamide

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM165641-1g	in stock	ǤŉǤư

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:943122-71-2; Formule moléculaire:C25H34N6O; Point de fusion:-; Code SMILES:O=C(C1=NC(NC2=CC=C(N3CCNCC3)C=C2)=NC=C1)NC4C(C5(C)C)(C)CCC5C4; Densité:

: Numéro de catalogue:CM165641; Poids moléculaire:434.59; Point d'ébullition:; N° Mdl:MFCD11977698; Stockage:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.